✦ LIBER ✦

Safety and feasibility of targeted agent combinations in solid tumours

✍ Scribed by Park, Sook Ryun; Davis, Myrtle; Doroshow, James H.; Kummar, Shivaani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1228 Phase I study of NGR-hTNF, a vascul

✍ G. Citterio; F.G. De Braud; V. Gregorc; T.M. De Pas; C. Noberasco; S. Boselli; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Safety and pharmacokinetics of motesanib

✍ Price, T J; Lipton, L; McGreivy, J; McCoy, S; Sun, Y-N; Rosenthal, M A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 167 KB

Biological insights into effective and a

✍ Ocaña, Alberto; Freedman, Orit; Amir, Eitan; Seruga, Bostjan; Pandiella, Atanasi 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 499 KB

Impact of targeted neoadjuvant therapies

✍ Waddell, T.; Cunningham, D. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Phase I safety and pharmacokinetic study

✍ M.J.A. de Jonge; H. Dumez; J.J.E.M. Kitzen; B. Beuselinck; J. Verweij; R. Courtn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Defining the optimal biological dose of

✍ Vanesa Gregorc; Giovanni Citterio; Giordano Vitali; Anna Spreafico; Paola Scifo; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 356 KB